Drug Alternatives News 2007-04-05
-
Callisto Intends to Move Guanilib into Clinical Trials in … – Earthtimes.org
Callisto Intends to Move Guanilib into Clinical Trials in …
Earthtimes.org -2 hours ago
… activity against resistant diseases andsignificantly reduced cardiotoxicity, or damage to the heart, compared tocurrently available drug alternatives. … -
Callisto Pharmaceuticals Announces Patient Dosing in L-Annamycin … – Drug Newswire (press release)
Callisto Pharmaceuticals Announces Patient Dosing in L-Annamycin …
Drug Newswire (press release), CT -Apr 3, 2007
… activity against resistant diseases and significantly reduced cardiotoxicity, or damage to the heart, compared to currently available drug alternatives. … -
Callisto Pharmaceuticals Opens Additional Site for Phase II … – Earthtimes.org
Callisto Pharmaceuticals Opens Additional Site for Phase II …
Earthtimes.org -Mar 12, 2007
… activity against resistant diseases andsignificantly reduced cardiotoxicity, or damage to the heart, compared tocurrently available drug alternatives. … -
Nature's Mood Boosters – Mother Earth News
Nature's Mood Boosters
Mother Earth News, KS -Mar 20, 2007
… call-in radio program, is a contributing editor, for Psychology Today magazine and has devoted considerable research to the topic of drug alternatives. …
